|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | G01N 33/68 | (2006.01) |
| (11) | Patento numeris | 3359967 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16787748.9 |
| Europos patento paraiškos padavimo data | 2016-10-06 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-08-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-08-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2016/073880 |
| Data | 2016-10-06 |
| (87) | Numeris | WO 2017/060353 |
| Data | 2017-04-13 |
| (30) | Numeris | Data | Šalis |
| 201562237910 P | 2015-10-06 | US |
| (72) |
SCHAFER, Peter H. , US
TROTTER, Matthew William Burnell , ES
|
| (73) |
Amgen (Europe) GmbH ,
Floor 6-8
Suurstoffi 22, 6343 Risch-Rotkreuz,
CH
|
| (54) | METHODS FOR TREATING INFLAMMATORY AND OTHER DISEASES AND THE USE OF BIOMARKERS AS PREDICTORS OF CLINICAL SENSITIVITY TO TREATMENT WITH APREMILAST |
| METHODS FOR TREATING INFLAMMATORY AND OTHER DISEASES AND THE USE OF BIOMARKERS AS PREDICTORS OF CLINICAL SENSITIVITY TO TREATMENT WITH APREMILAST |